The combination of a new $30.9M Yorkville facility (on top of the existing $100M facility) and the registration of 7.5M resale shares signals aggressive capital raising through potentially highly dilutive variable-rate convertible debt. Monitor conversion activity and stock price relative to the $1.86 floor price, as sustained VWAP below floor triggers amortization events requiring cash payments. The going-concern qualifications at all four operating subsidiaries and the denied motion to dismiss in the Jones Day lawsuit add to the risk profile.
Executive Summary
EM&T files Pre-Effective Amendment No. 1 to its S-1 registration statement to register up to 7,500,000 shares of common stock for resale by YA II PN, Ltd. (Yorkville). The shares are issuable upon conversion of the remaining $12.4M principal balance of the First Convertible Debenture from the May 2026 Yorkville financing. The company also discloses a new $30.9M convertible debenture facility with Yorkville entered on September 17, 2026, with a $22M first tranche already issued. The filing reveals that all four Korean operating subsidiaries (KCM, KMMI, NS World, Handa Lab) have going-concern qualifications from their auditors and that the company faces a material lawsuit from Jones Day seeking ~$3.9M.
Key Facts
- Registering up to 7,500,000 shares for resale by Yorkville (YA II PN, Ltd.) upon conversion of remaining $12,434,765.15 principal of First Debenture.
- New $30,927,835 convertible debenture facility with Yorkville entered September 17, 2026; first tranche of $22,000,000 already issued.
- All four Korean subsidiaries (KCM, KMMI, NS World, Handa Lab) have going-concern qualifications in their audited financials.
- EM faces a material lawsuit from Jones Day seeking ~$3.9 million in damages; motion to dismiss was denied.
- David Wilcox controls ~66.63% of voting power through The Zeus Trust.
- 627,200,646 shares outstanding as of September 22, 2026; last reported price $3.72.
- The company has incurred operating losses and expects to continue incurring significant expenses.
Financial Impact
Up to $12.4M of remaining convertible debt can be converted into up to 7.5M shares at a variable conversion price (lower of $12.09 or 95% of 5-day VWAP, floor $1.86), creating significant potential dilution. A new $30.9M convertible facility adds further dilution risk.
Risk Factors
- Massive dilution from up to $130.9M in Yorkville convertible debentures with variable conversion prices (95% of VWAP, floor $1.86).
- All four Korean operating subsidiaries have going-concern qualifications from auditors.
- Material lawsuit from Jones Day seeking ~$3.9M; motion to dismiss denied, litigation proceeding.
- Pre-revenue/early-stage company with limited operating history as a consolidated public entity.
- Controlled company structure with 66.63% voting control by Executive Chairman David Wilcox.
- Nasdaq compliance risk (previously received deficiency notice for late 10-Q filing).
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001213900-26-102787 |
| Document: ea030449902ex4-20.htm | 0001213900-26-102787 |
| Document: 0001213900-26-102787-index-headers.html | 0001213900-26-102787 |
| Document: 0001213900-26-102787-index.html | 0001213900-26-102787 |
| Document: 0001213900-26-102787.txt | 0001213900-26-102787 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | 8-K | $1.54 | awaiting T+20 | — | $1.41 (−8.44%) |
Oct 15, 2026 11d ago | Press Release | $1.54 | awaiting T+20 | — | $1.41 (−8.44%) |
Oct 14, 2026 12d ago | 8-K | $1.50 | awaiting T+20 | — | $1.41 (−6.00%) |
Oct 13, 2026 13d ago | EFFECT | $1.43 | awaiting T+20 | — | $1.41 (+1.05%) |
Oct 9, 2026 17d ago | 8-K | $1.64 | awaiting T+20 | — | $1.41 (−14.02%) |
Oct 8, 2026 18d ago | 3 | $1.64 | awaiting T+20 | — | $1.41 (−14.02%) |
Oct 6, 2026 20d ago | Press Release | $1.92 | awaiting T+20 | — | $1.41 (−26.56%) |
Oct 6, 2026 20d ago | 8-K | $1.92 | awaiting T+20 | — | $1.41 (−26.56%) |
Oct 6, 2026 20d ago | EFFECT | $1.92 | awaiting T+20 | — | $1.41 (+26.56%) |
Oct 5, 2026 21d ago | S-1 | $1.92 | awaiting T+20 | — | $1.41 (+26.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers